BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34624565)

  • 1. Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells.
    Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
    Tissue Cell; 2021 Dec; 73():101655. PubMed ID: 34624565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
    Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
    Deng H; Gong X; Ji G; Li C; Cheng S
    Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway.
    Ma S; Wang Q; Ma X; Wu L; Guo F; Ji H; Liu F; Zhao Y; Qin G
    Tumour Biol; 2016 Jan; 37(1):989-98. PubMed ID: 26264613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway.
    Zhao JJ; Hao S; Wang LL; Hu CY; Zhang S; Guo LJ; Zhang G; Gao B; Jiang Y; Tian WG; Luo DL
    Oncotarget; 2016 Sep; 7(36):57903-57918. PubMed ID: 27507052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7a Inhibits Tumor Metastasis by Regulating TGF-β/Smad Signaling in the Colorectal Adenocarcinoma Cell Line LS-174T.
    Cao W; Wang Q; Huang C
    Anticancer Res; 2021 Aug; 41(8):3801-3808. PubMed ID: 34281839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
    Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
    J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck.
    Yu C; Liu Y; Huang D; Dai Y; Cai G; Sun J; Xu T; Tian Y; Zhang X
    Oncol Rep; 2011 Jun; 25(6):1581-7. PubMed ID: 21479366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of transforming growth factor-beta1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-beta/Smad pathway.
    Xiao J; Xiang Q; Xiao YC; Su ZJ; Huang ZF; Zhang QH; Tan Y; Li XK; Huang YD
    J Exp Clin Cancer Res; 2010 Apr; 29(1):35. PubMed ID: 20416076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of Rap1GAP Expression Activates the TGF-
    Yan Z; Yangyanqiu W; Shuwen H; Jing M; Haihong L; Gong C; Yin J; Qing Z; Weili G
    Biomed Res Int; 2021; 2021():6840642. PubMed ID: 34840979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling.
    Lee YJ; Park JH; Oh SM
    Biochem Biophys Res Commun; 2020 Jan; 522(1):270-277. PubMed ID: 31757421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wulong Xiaozheng Wan medicated serum inhibits epithelial-mesenchymal transition in human gastric carcinoma cell line BGC823 by modulation of transforming growth factor-β1/Smad signaling.
    Zhang Y; Wang B; Yang L; Li D; Yuan X; Guo X
    J Tradit Chin Med; 2019 Jun; 39(3):380-392. PubMed ID: 32186010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.
    Zhou YH; Liao SJ; Li D; Luo J; Wei JJ; Yan B; Sun R; Shu Y; Wang Q; Zhang GM; Feng ZH
    PLoS One; 2013; 8(5):e65906. PubMed ID: 23734265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
    Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
    Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-β1-induced epithelial-mesenchymal transition in gastric cancer.
    You X; Wu J; Zhao X; Jiang X; Tao W; Chen Z; Huang C; Zheng T; Shen X
    Aging (Albany NY); 2021 Jul; 13(14):18464-18481. PubMed ID: 34260413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.